The S&P 500 and the Dow vaulted to record highs one day after the rate cut. Stocks rallied to record highs this week in the ...

The Dow closed at a record high on Friday. Investors see more gains ahead as the Fed kicks off a new cycle of easing interest ...

If you're attracted to lower-priced stocks under $20 and see value in diversifying your portfolio to include this category of ...

US stocks closed the session mixed on Friday, with the Dow Jones Industrial Average ( ^DJI) eking out another record to close ...

US equity futures slipped on Friday as some bad news on earnings tempered the euphoria around the trajectory for interest ...

Fed commentary could give a further shot in the arm to AI names that have been market leaders, but the broader semiconductor ...

U.S. stock index futures on Friday were largely flat, a day after Wall Street ripped gains on soft landing hopes sparked by ...

U.S. stocks drifted around their all-time highs, as a record-setting week for Wall Street closed on a quieter note ...

If the Fed does fail to achieve a “soft-landing,” Nvidia, Tesla and others can be viewed as a potential defensive play for ...

Mondelez International (NASDAQ: MDLZ) is a snack food company that generated $36 billion in sales in 2023 and is present in ...

Is “buy the dip” good advice? Discover how to create a buy the dip strategy and how it can grow your stock portfolio.

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.